MAPT and Alzheimer disease: Concomitant activation of cdc2, cdk4, and cdk5 in neurodegenerating neurons has been described in AD and concurrent p25 accumulation, cdk5 activation, and tau hyperphosphorylation were also observed in the postmortem brains of AD patients.